TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/30/23 18:40 | 1/26/23 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Donegan Michael C | FL | O | Prin. Fi | S.dm | -9 | 5.08 | 0 | -2 | -13 | 12 | D | ||||||||||||||
1/25/23 17:50 | 1/23/23 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Donegan Michael C | FL | O | Prin. Fi | S.dm | -7 | 5.34 | 0 | -1 | -15 | 8 | D | ||||||||||||||
12/9/22 19:37 | 12/6/22 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Donegan Michael C | FL | O | Interim | S.d | -4 | 4.78 | 0 | -1 | -17 | 5 | D | ||||||||||||||
12/2/21 06:30 | 11/30/21 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Donegan Michael C | FL | O | CAO,VP o | S.d | -16 | 0.5353 | 0 | -30 | -23 | 99 | D | ||||||||||||||
5/12/21 20:44 | 5/11/21 | TXMD | Therapeuticsmd, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Donegan Michael C | FL | O | CAO,VP F | S.d | -5 | 1.04 | 0 | -5 | -25 | 14 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |